RNU7-82P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU7-82P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU7-82P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU7-82P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-82P expression acts as an unfavorable survival marker.

KIRC, UCEC, and BRCA are the cancer types where RNU7-82P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCDFSTertileIII,IV0.1270.744.002108view →
UCECDFSTertileAll0.6930.899<.001108view →
BRCADFSTertileIII,IV0.3730.796.04018view →
BLCADFSTertileAll0.0960.626<.00118view →
LUADOSTertileAll0.2350.697.01018view →
Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU7-82P–KIRC (DFS)

Kaplan–Meier survival curve for RNU7-82P RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration